ArticleJournal of medical genetics2002
High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH).
Article in Journal of medical genetics, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 89 citations in OpenAlex.
- Copy number variation analysis by ligation-dependent PCR based on magnetic nanoparticles and chemiluminescence.Theranostics · 2015Article
- Quadruplex MAPH: improvement of throughput in high-resolution copy number screening.BMC genomics · 2009Article
- Directional and balancing selection in human beta-defensins.BMC evolutionary biology · 2008Article
- Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome.Human genetics · 2007Article
- Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA.BMC genomics · 2006Article
- Strategies for the detection of copy number and other structural variants in the human genome.Human genomics · 2006Review
- Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis.Journal of negative results in biomedicine · 2005Article
- Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.Familial cancer · 2005Article
- Molecular karyotyping using an SNP array for genomewide genotyping.Journal of medical genetics · 2004Article
- A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation.BMC medical genetics · 2004Article
- Genomic imbalances in mental retardation.Journal of medical genetics · 2004Article
- Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster.American journal of human genetics · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubtelomeric regions of the human genome are gene rich, with a high level of sequence polymorphism. A number of clinical conditions, including learning disability, have been attributed to subtelomeric deletions or duplications, but screening for deletion in these regions using conventional cytogenetic methods and fluorescence in situ hybridisation (FISH) is laborious. Here we report that a new method, multiplex amplifiable probe hybridisation (MAPH), can be used to screen for copy number at subtelomeric regions.
methodsWe have constructed a set of MAPH probes with each subtelomeric region represented at least once, so that one gel lane can assay copy number at all chromosome ends in one person. Each probe has been sequenced and, where possible, its position relative to the telomere determined by comparison with mapped clones.
resultsThe sensitivity of the probes has been characterised on a series of cytogenetically verified positive controls and 83 normal controls were used to assess the frequency of polymorphic copy number with no apparent phenotypic effect. We have also used MAPH to test a cohort of 37 people selected from males referred for fragile X syndrome testing and found six changes that were confirmed by dosage PCR.
conclusionsMAPH can be used to screen subtelomeric regions of chromosomes for deletions and duplications before confirmation by FISH or dosage PCR. The high throughput nature of this technique allows it to be used for large scale screening of subtelomeric copy number, before confirmation by FISH. In practice, the availability of a rapid and efficient screen may allow subtelomeric analysis to be applied to a wider selection of patients than is currently possible using FISH alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.